<?xml version="1.0" encoding="UTF-8"?>
<ref id="B23-pharmaceuticals-12-00157">
 <label>23.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Parra</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Lizarazo</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Jorge</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Jimenez-Arango</surname>
    <given-names>J.A.</given-names>
   </name>
   <name>
    <surname>Zea-Vara</surname>
    <given-names>A.F.</given-names>
   </name>
   <name>
    <surname>Gonzalez-Manrique</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Vargas</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Angarita</surname>
    <given-names>J.A.</given-names>
   </name>
   <name>
    <surname>Zuniga</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Lopez-Gonzalez</surname>
    <given-names>R.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Guillain–Barré Syndrome Associated with Zika Virus Infection in Colombia</article-title>
  <source>N. Engl. J. Med.</source>
  <year>2016</year>
  <volume>375</volume>
  <fpage>1513</fpage>
  <lpage>1523</lpage>
  <pub-id pub-id-type="doi">10.1056/NEJMoa1605564</pub-id>
  <pub-id pub-id-type="pmid">27705091</pub-id>
 </element-citation>
</ref>
